| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Beau M. Ances | Q41716869 |
| P2093 | author name string | Serena S Spudich | |
| P2860 | cites work | Structural and functional features of central nervous system lymphatic vessels | Q27316769 |
| HIV protease inhibitor exposure predicts cerebral small vessel disease | Q33807507 | ||
| HIV-associated neurocognitive disorder. | Q33939729 | ||
| Brain alterations within the first 100 days of HIV infection | Q34994446 | ||
| Controversies in HIV-associated neurocognitive disorders | Q35037015 | ||
| HIV status and the risk of ischemic stroke among men. | Q35611619 | ||
| Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation | Q35822465 | ||
| Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. | Q36072424 | ||
| Cerebral white matter integrity during primary HIV infection | Q37028677 | ||
| Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. | Q37393465 | ||
| Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND) | Q38258410 | ||
| Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial | Q41466517 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Topics in antiviral medicine | Q26841872 |
| P1476 | title | CROI 2016: Neurologic Complications of HIV Infection | |
| P478 | volume | 24 |
Search more.